Skip to main contentSkip to main content
Updating results

Naloxone

  • Updated

FRIDAY, Dec. 16, 2022 (HealthDay News) -- There is a higher risk for adverse dental outcomes associated with sublingual buprenorphine/naloxone compared with transdermal buprenorphine or oral naltrexone, according to a research letter published in the Dec. 13 issue of the Journal of the American Medical Association.

  • Updated

THURSDAY, Dec. 15, 2022 (HealthDay News) -- The implementation of an automated harm reduction dispensing machine is associated with increased access and use of harm reduction products and services, according to a study published online Nov. 11 in the Journal of the American Pharmacists Association.

  • Updated

WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday warned health care workers to look out for patients who may have been exposed to a potentially deadly animal sedative, possibly through illicit drug use. The veterinary medication xylazine is sometimes added to fentanyl, heroin, or other drugs after either being diverted from the legal animal supply or illicitly produced, the FDA said.

WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday warned health care workers to look out for patients who may have been exposed to a potentially deadly animal sedative, possibly through illicit drug use.

  • Updated

WEDNESDAY, Aug. 31, 2022 (HealthDay News) -- Fentanyl, the synthetic opioid that's driving a surge in drug overdose deaths, kills by stopping breathing even before someone loses consciousness, a new study reveals.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News